Following advice in response to COVID-19, 3 public evidence gathering days which were being arranged by the ACMD to inform reports on young people’s drug use and naloxone provision have been postponed until further notice.
We are instead inviting relevant stakeholders to provide written submissions to help support these workstreams. If you would like to submit written evidence please use the forms provided and return to Robert.wolstenholme@phe.gov.uk copying in the ACMD secretariat acmd@homeoffice.gov.uk. The period for written submissions will remain open until Wednesday 30 September 2020.
The ACMD are particularly interested in hearing from stakeholders that are able to provide evidence on the following areas for young people:
- prevalence and nature of drug use among young people
- evidence of effective treatment
- descriptions of interventions or treatment models being used
- how responses could be improved
- case studies of note
And for naloxone:
- prevalence and nature of naloxone provision, carriage and use
- evidence of effectiveness of naloxone provision in different settings
- evidence of who is administering naloxone (police, voluntary services, etc.)
- barriers to uptake of naloxone (both intramuscular and intranasal naloxone)
- evidence of collaborative approaches to provision
- case studies of note